News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,990 Results
Type
Article (88163)
Company Profile (825)
Press Release (783983)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233344)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18429)
Job Trends (17439)
News (398109)
Policy (39991)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (40)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (373)
Approvals (18628)
Artificial intelligence (676)
Autoimmune disease (189)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (172)
Brain cancer (68)
Breast cancer (692)
Cancer (5302)
Cardiovascular disease (469)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (66)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77355)
Collaboration (1938)
Company closure (5)
Compensation (1222)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (956)
Cystic fibrosis (155)
Data (6623)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7315)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (257)
Earnings (100693)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135752)
Executive appointments (1068)
FDA (21781)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1630)
Gene editing (230)
Generative AI (71)
Gene therapy (711)
GLP-1 (1164)
Government (5477)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (308)
Immuno-oncology (75)
Indications (128)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17970)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (395)
Machine learning (48)
Management (66)
Manufacturing (916)
MASH (182)
Medical device (15086)
Medtech (15150)
Mergers & acquisitions (23031)
Metabolic disorders (1470)
mRNA (201)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (382)
Neuropsychiatric disorders (108)
Neuroscience (3235)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (717)
Opinion (347)
Ovarian cancer (173)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (316)
Partnered (39)
Patents (544)
Patient recruitment (545)
Peanut (64)
People (67131)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23904)
Phase 2 (33567)
Phase 3 (25284)
Pipeline (5953)
Policy (357)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (270)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (996)
Real estate (7444)
Recruiting (81)
Regulatory (29316)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1189)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (178)
Last 7 days (950)
Last 30 days (3173)
Last 365 days (32834)
2026 (5303)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51676)
Australia (9081)
California (12132)
Canada (3453)
China (1223)
Colorado (512)
Connecticut (526)
Delaware (361)
Europe (118890)
Florida (1801)
Georgia (393)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (79)
Indiana (572)
Iowa (24)
Japan (461)
Kansas (135)
Kentucky (47)
Louisiana (31)
Maine (84)
Maryland (1509)
Massachusetts (8890)
Michigan (379)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3253)
New Mexico (33)
New York (3199)
North Carolina (1673)
North Dakota (10)
Northern California (5865)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2415)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4697)
Tennessee (185)
Texas (1908)
United States (43637)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1008)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 872,990 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ionis to present new data supporting DAWNZERA™ (donidalorsen) in hereditary angioedema at 2026 AAAAI Annual Meeting
February 27, 2026
·
6 min read
Press Releases
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
February 27, 2026
·
17 min read
Press Releases
MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes
February 27, 2026
·
4 min read
Press Releases
Medical Component Specialists Expands Global Footprint with New State-of-the-Art Manufacturing Facility in Costa Rica
February 27, 2026
·
3 min read
Press Releases
Tidewave Bio Appoints Prof. Alexander M.M. Eggermont, MD, PhD, as Head of Clinical Advisory Board
February 27, 2026
·
2 min read
Press Releases
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
February 27, 2026
·
8 min read
Press Releases
Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome
February 27, 2026
·
4 min read
Press Releases
European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19
February 27, 2026
·
6 min read
Press Releases
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
February 27, 2026
·
23 min read
Press Releases
ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE
February 27, 2026
·
4 min read
1 of 87,299
Next
